Table 3.

Risk for adverse outcomes among women with uterine tamponade and interventional radiology procedures

	Uterine tamponade procedures
	Morbidity composite			Transfusion			Hysterectomy
	Absent	Present	Percent	Absent	Present	Percent	Absent	Present	Percent
Year
2006	n/a	≤10	n/a	330	41	11.1%	n/a	≤10	n/a
2007	473	15	3.1%	431	57	11.7%	n/a	≤10	n/a
2008	495	23	4.4%	434	84	16.2%	505	13	2.5%
2009	599	36	5.7%	509	126	19.8%	611	24	3.8%
2010	703	45	6.0%	587	161	21.5%	719	29	3.9%
2011	806	80	9.0%	663	223	25.2%	845	41	4.6%
2012	955	99	9.4%	728	326	30.9%	993	61	5.8%
2013	952	97	9.2%	740	309	29.5%	994	55	5.2%
2014	824	103	11.1%	593	334	36.0%	871	56	6.0%
Interventional radiology procedures
	Morbidity composite			Transfusion			Hysterectomy
	Absent	Present	Percent	Absent	Present	Percent	Absent	Present	Percent
Year
2006	67	28	29.5%	28	67	70.5%	80	15	15.8%
2007	61	29	32.2%	32	49	60.5%	n/a	≤10	n/a
2008	60	30	33.3%	28	62	68.9%	76	14	15.6%
2009	77	39	33.6%	49	67	57.8%	94	22	19.0%
2010	88	45	33.8%	49	84	63.2%	103	30	22.6%
2011	115	58	33.5%	73	100	57.8%	142	31	17.9%
2012	108	73	40.3%	71	110	60.8%	146	35	19.3%
2013	112	71	38.8%	71	112	61.2%	147	36	19.7%
2014	93	54	36.7%	66	81	55.1%	111	36	24.5%

Cell sizes ≤10 restricted to preserve patient confidentiality. Morbidity composite includes the 18 diagnoses in the CDC severe maternal morbidity composite excluding hysterectomy and transfusion. Temporal trends for each outcome for both UT and IR procedures were statistically significant (p<0.01).